Search Results 231-240 of 38816 for Two-phase

  1. Publications - Jian L. Campian, M.D., Ph.D. - Mayo Clinic

    A Phase 1/2 Study of Disulfiram and Copper With Concurrent Radiation Therapy and Temozolomide for Patients With Newly Diagnosed Glioblastoma. Int J Radiat ...

  2. A Study to Evaluate Telisotuzumab Vedotin (ABBV-399) in Subjects with Previously Treated c-Met+ Non-Small Cell Lung Cancer - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  3. Alzheimer's Disease Clinical Trials - Mayo Clinic Research

    The purpose of this study is to provide subjects who have completed participation in a Phase 2 or Phase 3 trial with TRx0237 continued access to therapy and to ...

  4. A Study of AMG 757 in Participants With Neuroendocrine Prostate Cancer - Mayo Clinic

    The purpose of this study is to evaluate the safety and tolerability of AMG 757, and to determine the maximum tolerated dose (MTD) or recommended phase 2 dose ( ...

  5. Tongue cancer - Symptoms and causes - Mayo Clinic

    For healthy adults, that means up to one drink a day for women and up to two drinks a day for men. ... Treatment of stage I and II (early) head and neck ...

  6. A Study of the Natural History of Leukocyte Chemotactic Factor 2 Amyloidosis (ALECT2) Disease - Mayo Clinic

    Participants who have already reached end-stage renal disease (ESRD) will provide retrospective chart review data and biological specimens at baseline only.

  7. Phase II Study Evaluating Combination Chemotherapy + Radiotherapy (RT) with Avelumab in Muscle Invasive Bladder Cancer - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  8. Endometrial Cancer Clinical Trials - Mayo Clinic Research

    ... phase 2 dose (RP2D) 1.1.2 To evaluate the safety and tolerability of this combination in a dose expansion cohort in patients with uterine serous carcinoma.

  9. Kidney Cancer Clinical Trials - Mayo Clinic Research

    Mayo Clinic will be participating in both Part A (Phase 1) & (Phase 2) B of the study. ... There are two parts in this study. During the escalation part ...

  10. A Study to Evaluate the Safety, Pharmacokinetics, and Anti-tumor Activity of LYT-200 Alone and Combined with Chemotherapy or Tislelizumab to Treat Patients with Metastatic Solid Tumors - Mayo Clinic

    The purpose of this study is to establish the safety and tolerability, and to determine the recommended Phase 2 dose (RP2D) for LYT-200. Participation ...